98%
921
2 minutes
20
Background: Transcatheter aortic valve replacement (TAVR) has greatly expanded the treatment options available for patients with severe aortic stenosis at high surgical risk.
Materials And Methods: We compared changes in myocardial function in TAVR with a transfemoral (TF) versus a transapical (TA) approach at a major tertiary hospital from 2012-2016. Traditional echocardiographic measures of cardiac structure and function were tracked, alongside the use of two-dimensional speckle tracking echocardiography to measure myocardial strain and strain rates.
Results: For the entire cohort with complete data at all time points (n = 42), between the pre-TAVR baseline (mean: 20.1 d) and the post-TAVR 1-mo follow-up (mean: 32.7 d), global longitudinal strain significantly increased (from -15.6% to -18.2%, P < 0.001). When comparing the TF (n = 31) and TA (n = 11) groups, TA patients showed persistently impaired apical longitudinal strain at the 1-mo follow-up (-15.9% versus -22.3%, P < 0.05). In terms of clinical outcomes, both groups (n = 131 for TF, n = 53 for TA) were similar in terms of 30-d mortality, readmission rate, and risk of post-TAVR acute kidney injury. However, TA patients experienced significantly longer length of hospitalization (7.58 versus 3.92 d, P = 0.02), intensive care unit hours (105.4 versus 47.1 h, P = 0.02), and were at a greater risk of long-term (>72 h) intensive care unit stay (45% versus 25%, P = 0.01).
Conclusions: Patients undergoing TA-TAVR exhibit impaired apical longitudinal strain, although global myocardial function is similar to TF-TAVR otherwise. Myocardial strain measured by two-dimensional speckle tracking echocardiography appears to be a sensitive method to detect subtle cardiac remodeling after TAVR.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jss.2017.08.036 | DOI Listing |
Neuroradiol J
September 2025
Department of Neurosurgery, National Hospital Organization Yokohama Medical Center, Japan.
BackgroundMechanical thrombectomy (MT) is a well-established treatment for acute large-vessel occlusion. While the transfemoral approach (TFA) is the standard, it can be challenging in elderly patients with tortuous vasculature. The transbrachial approach (TBA) offers a shorter and more direct route but is associated with more puncture site complications.
View Article and Find Full Text PDFCatheter Cardiovasc Interv
September 2025
Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
Background: With transcatheter aortic valve implantation (TAVI) now extending to lower-risk and younger patients, optimizing procedural and hemodynamic outcomes is critical. The Myval Octacor, a new balloon-expandable valve (BEV), was developed to improve outcomes by reducing paravalvular regurgitation (PVL), minimizing pacemaker implantation (PPI) rates, and enhancing hemodynamic performance. However, limited data are available comparing Myval Octacor to contemporary self-expanding supra-annular valves (SEVs) Evolut PRO/PRO+ and Acurate Neo2.
View Article and Find Full Text PDFAnn Med Surg (Lond)
September 2025
Department of Medicine, Nangarhar Medical University, Jalalbad, Afghanistan.
Background: Transcatheter aortic valve implantation (TAVI) requires a primary access to deliver the valve and a secondary access for angiographic guidance. Although transfemoral access (TFA) is most commonly employed, alternative access sites are gaining traction. This systematic review and meta-analysis compares the efficacy and safety of transradial (TRA) and TF secondary access.
View Article and Find Full Text PDFJ Clin Med
August 2025
Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, School of Medicine & Health, Technical University of Munich, 80636 Munich, Germany.
The novel Navitor intra-annular self-expandable transcatheter aortic valve prosthesis is designed to improve coronary access, reduce paravalvular leaks, and enhance hemodynamic performance. Comparative data with the established Evolut platform (R, Pro, FX) are still lacking. This study aimed to evaluate the short-term clinical outcomes of Navitor (NAV) versus Evolut transcatheter heart valves.
View Article and Find Full Text PDFCirculation
August 2025
Heart Center Leipzig at Leipzig University, Leipzig, Germany; Leipzig Heart Science, Leipzig, Germany.
Background: Minimalist treatment strategies for transcatheter aortic valve implantation (TAVI) have been widely adopted due to continued procedural evolution, but large randomized trials are lacking. The DOUBLE-CHOICE trial evaluated safety and efficacy of a minimalist approach (MA) compared with standard of care (SoC) for transfemoral TAVI.
Methods: In this investigator-initiated, 2x2 factorial, open-label, randomized, multicenter, non-inferiority trial, patients with symptomatic aortic stenosis were included at 10 German sites.